Kiran RP - Search Results

1

Adenoma detection rate in high-risk patients differs from that in average-risk patients.

Sanaka MR, Rai T, Navaneethan U, Gohel TD, Podugu A, Thota PN, Lopez R, Kiran RP, Burke CA. Sanaka MR, et al. Among authors: kiran rp. Gastrointest Endosc. 2016 Jan;83(1):172-8. doi: 10.1016/j.gie.2015.04.019. Epub 2015 May 27. Gastrointest Endosc. 2016. PMID: 26024584

2

Preoperative colorectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy.

Kariv R, Remzi FH, Lian L, Bennett AE, Kiran RP, Kariv Y, Fazio VW, Lavery IC, Shen B. Kariv R, et al. Among authors: kiran rp. Gastroenterology. 2010 Sep;139(3):806-12, 812.e1-2. doi: 10.1053/j.gastro.2010.05.085. Epub 2010 Jun 9. Gastroenterology. 2010. PMID: 20537999

3

Factors associated with operative recurrence early after resection for Crohn's disease.

Khoury W, Strong SA, Fazio VW, Kiran RP. Khoury W, et al. Among authors: kiran rp. J Gastrointest Surg. 2011 Aug;15(8):1354-60. doi: 10.1007/s11605-011-1552-4. Epub 2011 May 28. J Gastrointest Surg. 2011. PMID: 21626229

4

Risk of postoperative venous thromboembolism after laparoscopic and open colorectal surgery: an additional benefit of the minimally invasive approach?

Shapiro R, Vogel JD, Kiran RP. Shapiro R, et al. Among authors: kiran rp. Dis Colon Rectum. 2011 Dec;54(12):1496-502. doi: 10.1097/DCR.0b013e31823302a1. Dis Colon Rectum. 2011. PMID: 22067177

5

Laparoscopic colorectal resection for cancer: effects of conversion on long-term oncologic outcomes.

Rottoli M, Stocchi L, Geisler DP, Kiran RP. Rottoli M, et al. Among authors: kiran rp. Surg Endosc. 2012 Jul;26(7):1971-6. doi: 10.1007/s00464-011-2137-8. Epub 2012 Jan 12. Surg Endosc. 2012. PMID: 22237758

6

Severe disease on endoscopy and steroid use increase the risk for bowel perforation during colonoscopy in inflammatory bowel disease patients.

Navaneethan U, Kochhar G, Phull H, Venkatesh PG, Remzi FH, Kiran RP, Shen B. Navaneethan U, et al. Among authors: kiran rp. J Crohns Colitis. 2012 May;6(4):470-5. doi: 10.1016/j.crohns.2011.10.005. Epub 2011 Nov 17. J Crohns Colitis. 2012. PMID: 22398061

7

Temporal trends in colon neoplasms in patients with primary sclerosing cholangitis and ulcerative colitis.

Navaneethan U, Venkatesh PG, Lashner BA, Remzi FH, Shen B, Kiran RP. Navaneethan U, et al. Among authors: kiran rp. J Crohns Colitis. 2012 Sep;6(8):845-51. doi: 10.1016/j.crohns.2012.01.012. Epub 2012 Feb 8. J Crohns Colitis. 2012. PMID: 22398080

8

Severity of primary sclerosing cholangitis and its impact on the clinical outcome of Crohn's disease.

Navaneethan U, G K Venkatesh P, Lashner BA, Lopez R, Kiran RP, Shen B. Navaneethan U, et al. Among authors: kiran rp. J Crohns Colitis. 2012 Jul;6(6):674-80. doi: 10.1016/j.crohns.2011.11.020. Epub 2012 Jan 10. J Crohns Colitis. 2012. PMID: 22398102

9

Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.

Navaneethan U, Kochhar G, Venkatesh PG, Lewis B, Lashner BA, Remzi FH, Shen B, Kiran RP. Navaneethan U, et al. Among authors: kiran rp. Gastrointest Endosc. 2012 May;75(5):1045-1054.e1. doi: 10.1016/j.gie.2012.01.015. Epub 2012 Mar 8. Gastrointest Endosc. 2012. PMID: 22405258

10

The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis.

Navaneethan U, Venkatesh PG, Lashner BA, Shen B, Kiran RP. Navaneethan U, et al. Among authors: kiran rp. Aliment Pharmacol Ther. 2012 May;35(9):1045-53. doi: 10.1111/j.1365-2036.2012.05063.x. Epub 2012 Mar 19. Aliment Pharmacol Ther. 2012. PMID: 22428605

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters